Litcius/Paper detail

Targeting gliomas with STAT3-silencing nanoparticles

Padma Kadiyala, Jason V. Gregory, Pedro R. Löwenstein, Joerg Lahann, María G. Castro

2021Molecular & Cellular Oncology13 citationsDOIOpen Access PDF

Abstract

Glioblastoma is an aggressive brain tumor with poor prognosis. The brain is protected by the blood-brain barrier, which precludes transport of chemotherapeutics. We developed nanoparticles that achieve delivery of small-interfering RNA against Stat3 after systemic administration. Nanoparticles combined with radiation inhibited tumor progression and elicited anti-glioblastoma immunity in mice.

Topics & Concepts

Small interfering RNAGliomaGlioblastomaBlood–brain barrierCancer researchBrain tumorGene silencingSystemic administrationSTAT3ImmunityMedicineRNAChemistryBiologyImmune systemImmunologyCentral nervous systemPathologyInternal medicineCell biologySignal transductionGeneIn vivoBiochemistryBiotechnologyCytokine Signaling Pathways and InteractionsMicroRNA in disease regulationCancer Mechanisms and Therapy
Targeting gliomas with STAT3-silencing nanoparticles | Litcius